Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00277654
Recruitment Status : Completed
First Posted : January 16, 2006
Last Update Posted : December 13, 2011
Janssen Pharmaceuticals
University of Cincinnati
Information provided by (Responsible Party):
Lindner Center of HOPE